UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

Frontiers in immunology, 2018-04, Vol.9, p.557-557

Pranzatelli, Michael R

2018

Link zum Volltext

Verfügbarkeit prüfen

Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome

Brain & development (Tokyo. 1979), 2016-05, Vol.38 (5), p.439-448

2016

Link zum Volltext

Verfügbarkeit prüfen

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

Frontiers in neurology, 2017-09, Vol.8, p.468-468

2017

Link zum Volltext

Verfügbarkeit prüfen

Elevated cerebrospinal fluid C-X-C motif chemokine 10: Commonalities in paraneoplastic neurological disorders

Annals of neurology, 2016-11, Vol.80 (5), p.792-793

Pranzatelli, Michael R.

2016

Link zum Volltext

Verfügbarkeit prüfen

BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

Journal of neuroinflammation, 2013-01, Vol.10 (1), p.10-10, Article 806

2013

Link zum Volltext

Verfügbarkeit prüfen

B cell depletion therapy for new-onset opsoclonus-myoclonus

Movement disorders, 2010-01, Vol.25 (2), p.238-242

2010

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal Fluid Oligoclonal Bands in Childhood Opsoclonus-Myoclonus

Pediatric neurology, 2011-07, Vol.45 (1), p.27-33

2011

Link zum Volltext

Verfügbarkeit prüfen

Response to Correspondence on “Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome”

Journal of Child Neurology, 2013-03, Vol.28 (3), p.417-418

2013

Link zum Volltext

Verfügbarkeit prüfen

Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children

Pediatric blood & cancer, 2018-08, Vol.65 (8), p.e27097-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome

Pediatric neurology, 2017-08, Vol.73, p.48-56

2017

Link zum Volltext

Verfügbarkeit prüfen

Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping

Seminars in pediatric neurology, 2017-08, Vol.24 (3), p.229-239

2017

Link zum Volltext

Verfügbarkeit prüfen

Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS

Journal of neuroimmunology, 2018-08, Vol.321, p.150-156

2018

Link zum Volltext

Verfügbarkeit prüfen

Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges

Journal of the neurological sciences, 2017-10, Vol.381, p.285-290

2017

Link zum Volltext

Verfügbarkeit prüfen

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

Child neurology open, 2018, Vol.5, p.2329048X18795546

2018

Link zum Volltext

Verfügbarkeit prüfen

Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers

Cytokine (Philadelphia, Pa.), 2017-08, Vol.96, p.49-53

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome” [Pediatric Neurology 73 (2017) 48–56]

Pediatric neurology, 2018-01, Vol.78, p.84-84

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to Sharawat and Suther

Pediatric neurology, 2018-01, Vol.78, p.e3-e3

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome

Pediatric neurology, 2018-08, Vol.85, p.71-75

2018

Link zum Volltext

Verfügbarkeit prüfen

CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders

Journal of neuroimmunology, 2014-01, Vol.266 (1), p.75-81

2014

Link zum Volltext

Verfügbarkeit prüfen

Going with the flow: neuroinflammation

Developmental medicine and child neurology, 2011-09, Vol.53 (9), p.782-782

PRANZATELLI, MICHAEL R

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study

European journal of paediatric neurology, 2018-07, Vol.22 (4), p.586-594

2018

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS” [Cytokine 53 (2011) 384–389]

Cytokine (Philadelphia, Pa.), 2017-06, Vol.94, p.60-60

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Journal of Child Neurology, 2011-11, Vol.26 (11), p.1411-1421

2011

Link zum Volltext

Verfügbarkeit prüfen

Paraneoplastic movement disorders in childhood

Movement disorders, 2014-02, Vol.29 (2), p.281-281

2014

Link zum Volltext

Verfügbarkeit prüfen

Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay

Journal of interferon & cytokine research, 2013-09, Vol.33 (9), p.523

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(144)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

Elevated cerebrospinal fluid C-X-C motif chemokine 10: Commonalities in paraneoplastic neurological disorders

BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

B cell depletion therapy for new-onset opsoclonus-myoclonus

Cerebrospinal Fluid Oligoclonal Bands in Childhood Opsoclonus-Myoclonus

Response to Correspondence on “Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome”

Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children

Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome

Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping

Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS

Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers

Corrigendum to “Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome” [Pediatric Neurology 73 (2017) 48–56]

Response to Sharawat and Suther

Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome

CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders

Going with the flow: neuroinflammation

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study

Corrigendum to “Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS” [Cytokine 53 (2011) 384–389]

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Paraneoplastic movement disorders in childhood

Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay

Suchergebnisse filtern